These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6608394)

  • 21. Host genetic contribution to the cellular immune response to Chlamydia trachomatis: Heritability estimate from a Gambian twin study.
    Bailey RL; Natividad-Sancho A; Fowler A; Peeling RW; Mabey DC; Whittle HC; Jepson AP
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():45-50. PubMed ID: 20011694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to Chlamydia trachomatis.
    Brunham RC
    J Infect Dis; 2013 Jun; 207(12):1796-7. PubMed ID: 23470849
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines for Chlamydia infections of the female genital tract.
    Hafner LM; McNeilly C
    Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars.
    Starnbach MN; Bevan MJ; Lampe MF
    Infect Immun; 1995 Sep; 63(9):3527-30. PubMed ID: 7642287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathogenesis of chlamydia trachomatis infections in women.
    Debattista J; Timms P; Allan J; Allan J
    Fertil Steril; 2003 Jun; 79(6):1273-87. PubMed ID: 12798871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.
    Wang C; Tang J; Crowley-Nowick PA; Wilson CM; Kaslow RA; Geisler WM
    Clin Exp Immunol; 2005 Dec; 142(3):548-54. PubMed ID: 16297168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genital Chlamydia trachomatis infection in Australia.
    Amir L
    Med J Aust; 1993 Nov; 159(9):639-40. PubMed ID: 7694058
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response.
    Wilkinson NZ; Kingsley GH; Sieper J; Braun J; Ward ME
    Arthritis Rheum; 1998 May; 41(5):845-54. PubMed ID: 9588736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of three assays for serum IgA against Chlamydia trachomatis].
    Fuentes V; Anarratone F; Froissart M; Orfila J
    Pathol Biol (Paris); 1991 Feb; 39(2):117-21. PubMed ID: 2017335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chlamydia trachomatis: etiopathogenesis and diagnosis of infection].
    Friedek D; Ekiel A; Martirosian G
    Przegl Epidemiol; 2005; 59(3):723-30. PubMed ID: 16433314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DP restricted Chlamydia trachomatis specific synovial fluid T cell clones in Chlamydia induced Reiter's disease.
    Hermann E; Mayet WJ; Thomssen H; Sieper J; Poralla T; Meyer zum Büschenfelde KH; Fleischer B
    J Rheumatol; 1992 Aug; 19(8):1243-6. PubMed ID: 1404160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immunity to the mouse pneumonitis agent.
    Williams DM; Schachter J; Coalson JJ; Grubbs B
    J Infect Dis; 1984 Apr; 149(4):630-9. PubMed ID: 6233380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
    Barker CJ; Beagley KW; Hafner LM; Timms P
    Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein expression and immunity in chlamydial infections.
    Peeling RW; Mabey DC
    Infect Dis Obstet Gynecol; 1999; 7(1-2):72-9. PubMed ID: 10231013
    [No Abstract]   [Full Text] [Related]  

  • 36. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone.
    Igietseme JU; Ramsey KH; Magee DM; Williams DM; Kincy TJ; Rank RG
    Reg Immunol; 1993; 5(6):317-24. PubMed ID: 8068534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge.
    Picard MD; Cohane KP; Gierahn TM; Higgins DE; Flechtner JB
    Vaccine; 2012 Jun; 30(29):4387-93. PubMed ID: 22682294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs.
    Rank RG; Barron AL
    Infect Immun; 1983 Aug; 41(2):876-9. PubMed ID: 6603421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model.
    Olsen AW; Andersen P; Follmann F
    Vaccine; 2014 Feb; 32(6):685-92. PubMed ID: 24365515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The prevalence of anti-Chlamydia trachomatis and anti-Chlamydia pneumoniae antibodies in Brazzaville].
    Biendo M; Lefebvre JF; Fuentes V; Orfila J
    Bull Soc Pathol Exot; 1994; 87(2):85-8. PubMed ID: 8061533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.